# Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)

> **NCT02151812** · NA · COMPLETED · sponsor: **Hemoteq AG** · enrollment: 123 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Restenosis
- Coronary Atherosclerosis
- Coronary Arteriosclerosis

## Interventions

- **DEVICE:** Agent Paclitaxel-coated balloon
- **DEVICE:** SeQuent® Please Paclitaxel-coated Balloon

## Key facts

- **NCT ID:** NCT02151812
- **Lead sponsor:** Hemoteq AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-13
- **Primary completion:** 2017-04-27
- **Final completion:** 2019-10-28
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2019-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151812, "Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02151812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*